Literature DB >> 1870096

On the incidence of fits and mental retardation in tuberous sclerosis.

D W Webb1, A E Fryer, J P Osborne.   

Abstract

OBJECTIVES: To establish the frequency of fits and mental retardation in an unbiased group of tuberous sclerosis patients.
METHODS: Known tuberous sclerosis families with more than one affected person were ascertained for a genetic linkage study. A number of members were born after genetic counselling had been given after identification of the proband. These subjects were then carefully examined clinically and in many cases with cranial computerised tomography, renal ultrasound, and skeletal survey but not echocardiography. They provide an unbiased group of tuberous sclerosis patients and allow affected patients with normal intellect to be diagnosed. PATIENTS: Thirty-seven tuberous sclerosis families were ascertained and 26 patients born after the family proband were identified.
RESULTS: Sixteen of these 26 patients suffered fits (62%) and 10 patients were mentally retarded (38%).
CONCLUSIONS: A lower incidence of fits and mental retardation has been found in an unbiased sample of tuberous sclerosis patients. The lifetime risk for fits might be higher had we been able to follow the patients for longer. However, we believe these are more appropriate figures to use in genetic counselling for this disease.

Entities:  

Mesh:

Year:  1991        PMID: 1870096      PMCID: PMC1016904          DOI: 10.1136/jmg.28.6.395

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  11 in total

1.  Frequency of epiloia in Northern Ireland.

Authors:  O D FISHER; A C STEVENSON
Journal:  Br J Prev Soc Med       Date:  1956-07

Review 2.  Diagnosis of tuberous sclerosis.

Authors:  J P Osborne
Journal:  Arch Dis Child       Date:  1988-12       Impact factor: 3.791

3.  Tuberous sclerosis: prevalence in the Grampian region of Scotland.

Authors:  D Umapathy; A W Johnston
Journal:  J Ment Defic Res       Date:  1989-08

4.  Tuberous sclerosis: a genetic study.

Authors:  S Bundey; K Evans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-12       Impact factor: 10.154

5.  Tuberous sclerosis: a clinical and genetical investigation.

Authors:  J Zaremba
Journal:  J Ment Defic Res       Date:  1968-03

6.  Diagnostic and genetical aspects of tuberous sclerosis.

Authors:  N C Nevin; W G Pearce
Journal:  J Med Genet       Date:  1968-12       Impact factor: 6.318

7.  Evidence that the gene for tuberous sclerosis is on chromosome 9.

Authors:  A E Fryer; A Chalmers; J M Connor; I Fraser; S Povey; A D Yates; J R Yates; J P Osborne
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

8.  Tuberous sclerosis complex in children.

Authors:  H P Monaghan; B R Krafchik; D L MacGregor; C R Fitz
Journal:  Am J Dis Child       Date:  1981-10

9.  The tuberous sclerosis syndrome: clinical and EEG studies in 100 children.

Authors:  G Pampiglione; E J Moynahan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-07       Impact factor: 10.154

10.  Tuberous sclerosis: a new estimate of prevalence within the Oxford region.

Authors:  A Hunt; R H Lindenbaum
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

View more
  18 in total

Review 1.  Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation.

Authors:  Michael Wong
Journal:  Epilepsia       Date:  2007-08-28       Impact factor: 5.864

2.  Resting and task-modulated high-frequency brain rhythms measured by scalp encephalography in infants with tuberous sclerosis complex.

Authors:  Catherine Stamoulis; Vanessa Vogel-Farley; Geneva Degregorio; Shafali S Jeste; Charles A Nelson
Journal:  J Autism Dev Disord       Date:  2015-02

3.  Predictors of Drug-Resistant Epilepsy in Tuberous Sclerosis Complex.

Authors:  Anna Jeong; Jo Anne Nakagawa; Michael Wong
Journal:  J Child Neurol       Date:  2017-12       Impact factor: 1.987

4.  Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.

Authors:  Ling-Hui Zeng; Lin Xu; David H Gutmann; Michael Wong
Journal:  Ann Neurol       Date:  2008-04       Impact factor: 10.422

5.  Cardiac rhabdomyomas and their association with tuberous sclerosis.

Authors:  D W Webb; R D Thomas; J P Osborne
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

Review 6.  Anti-epileptogenic clinical trial designs in epilepsy: issues and options.

Authors:  Dieter Schmidt; Daniel Friedman; Marc A Dichter
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

7.  A cross sectional study of renal involvement in tuberous sclerosis.

Authors:  J A Cook; K Oliver; R F Mueller; J Sampson
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

Review 8.  Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.

Authors:  Michael Wong
Journal:  Epilepsia       Date:  2009-10-08       Impact factor: 5.864

9.  The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex.

Authors:  F J K O'Callaghan; T Harris; C Joinson; P Bolton; M Noakes; D Presdee; S Renowden; A Shiell; C N Martyn; J P Osborne
Journal:  Arch Dis Child       Date:  2004-06       Impact factor: 3.791

10.  The natural history of epilepsy in tuberous sclerosis complex.

Authors:  Catherine J Chu-Shore; Philippe Major; Susana Camposano; David Muzykewicz; Elizabeth A Thiele
Journal:  Epilepsia       Date:  2009-12-22       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.